ORGANIZATION AND BUSINESS (Details) - USD ($)		1 Months Ended			9 Months Ended
ORGANIZATION AND BUSINESS (Details) - USD ($)	Jul. 19, 2017	Jul. 31, 2016	Jun. 27, 2016	Apr. 30, 2016	Jul. 31, 2016	Apr. 01, 2016	Dec. 31, 2010	Jul. 31, 2009
Humavox [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage of interest purchased in acquisition			100.00%
Total purchase price			$ 16,000,000
Percentage of Company's common stock offered as consideration for acquisition			50.00%
Period of unconditional installments			24 months
Termination date for business acquisition agreement		Jul. 29, 2016
Humavox [Member] \| Warrants and options [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage of interest purchased in acquisition			100.00%
Humavox [Member] \| First installment amount [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Total purchase price			$ 5,500,000
Subsequent Event [Member] \| Medical technology business [Member] \| Scenario, Forecast [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Consideration owed for due diligence expenditures	$ 100,000
Consideration owed for additional due diligence expenditures	100,000
Common stock issuable as consideration for business acquisition at an issue price of USD$0.22	$ 2,500,000
Common stock issuance price per share	$ 0.22
Common stock issuable as consideration at issue price of USD$0.22 subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Common stock issuable as consideration at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion	$ 2,500,000
Issuance price per share for each milestone achieved	$ 0.22
Required capital to be raised by Company as part of acquisition agreement and as a condition to completion	$ 2,500,000
Subsequent Event [Member] \| Medical technology business [Member] \| Scenario, Forecast [Member] \| Maximum [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Purchase price	$ 7,500,000
PayItSimple [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investment amount						$ 15,000,000
Percentage purchase of interest						30.00%
Termination date for business acquisition agreement				Apr. 06, 2016
PayItSimple [Member] \| Total Interest Holding [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage purchase of interest						40.00%
PayItSimple [Member] \| Additional Investment [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investment amount						$ 7,500,000
Percentage purchase of interest						10.00%
Golden Target Pty Ltd, Principal Stockholder [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Percentage of entity owned		74.78%			74.78%
Percentage of interest purchased in acquisition								96.00%
Century Thrust Joint Venture Agreement [Member] \| Century Concession in Laos [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Aggregate percentage owned by unrelated entity							70.00%
Potential percentage of investee earnings attributable to Aurum if specified funding is provided by Aurum					72.86%
Potential ownership percentage if funding is provided by Aurum					51.00%

Aurum, Inc. 10-Q